Brief Article
Copyright ©2010 Baishideng.
World J Gastroenterol. Apr 28, 2010; 16(16): 2038-2045
Published online Apr 28, 2010. doi: 10.3748/wjg.v16.i16.2038
Table 1 Results of univariate Cox regression analysis
ParameterBχ2SEPHazard ratio
Child-Pugh classification0.5465.1890.2400.0231.727
Pre-treatment level of AFP0.2040.9210.2120.3371.226
Post-treatment level of AFP-0.93111.2380.2780.0010.394
Times of repeated TACE-0.50720.7340.111< 0.0010.602
Number of lesions-0.2180.9540.2230.3290.804
Pattern of tumor growth0.74316.5070.183< 0.0012.102
Tumor largest diameter0.13231.7080.023< 0.0011.141
Tumor product of diameters0.00930.9720.002< 0.0011.009
TV0.00138.4480.000< 0.0011.001
TTLVR0.66244.1130.100< 0.0011.938
Portal vein cancerous thrombus0.30416.8690.074< 0.0011.355
Tumor metastasis0.28710.1600.0900.0011.333
The degree of lipiodol retention0.33615.2080.086< 0.0011.399
TSR0.28613.0140.079< 0.0011.331
Table 2 Enter factors of multivariable Cox regression analysis
ParameterBχ2SEPHazard ratio
Post-treatment level of AFP-0.7315.4160.3140.0200.481
Times of repeated TACE-0.5978.7460.2020.0030.550
TTLVR0.76514.3280.202< 0.0012.150
Portal vein cancerous thrombosis0.3405.6430.1430.0181.405
Table 3 Cumulative survival ratios of different TTLVR subgroups
SubgroupCumulative survival rate (%)
Median survival (mo)Mean survival (mo)
6 mo12 mo24 mo36 mo60 mo
≥ 70%37.500.
Table 4 Correlations between largest tumor diameter, tumor product of the greatest axial dimension, TV, and TTLVR
ParameterTumor largest diameterTumor product of diametersTV
Tumor largest diameter0.9760.916
Tumor product of diameters0.928